The Claim
The percentage of p16-positive senescent cells in the endometrial stroma is not significantly different among women who achieve live birth, experience miscarriage, or have failed implantation during IVF.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The proportion of senescent cells marked by p16 in the uterine lining is the same in women who successfully give birth, have a miscarriage, or do not achieve implantation during IVF.
See the scientific wording
The percentage of p16-positive senescent cells in the endometrial stroma does not differ significantly between women with live birth, miscarriage, or failed implantation, indicating that stromal senescence is not a primary biomarker for IVF outcome in this population.
The number of senescent cells marked by p16 in the uterine lining's connective tissue stays the same whether an embryo implants successfully, fails to implant, or leads to miscarriage. These cells do not change in number based on the pregnancy outcome because their presence is controlled by the natural cycle of the uterine lining, not by whether an embryo is present or viable.
What the research says
1 studyStudy: Decreased number of p16-positive senescent cells in human endometrium as a marker of miscarriage
The study found that the number of p16-positive cells in the uterine connective tissue didn't change whether IVF succeeded, failed to implant, or ended in miscarriage — so these cells can't be used to predict IVF results.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.